Animal Sedative Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Animal Sedative Market is Segmented by Drug Class (Phenothiazines, Benzodiazepines, alpha-2 adrenergic Receptor Agonists, Butyrophenones, and Other Drug Classes), Application (Surgical, Diagnosis, and Clinical Research Studies), Route of Administration (Oral and Parenteral), Animal Type (Small and Large), and Geography (North America, Europe, Asia Pacific, and Rest of the World). The report offers the value (in USD million) for the above segments.

Animal Sedative Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Animal Sedative Market Size

Animal Sedative Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 239.27 Million
Market Size (2030) USD 317.18 Million
CAGR (2025 - 2030) 5.80 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Animal Sedative Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Animal Sedative Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Animal Sedative Market Analysis

The Global Animal Sedative Market size is estimated at USD 239.27 million in 2025, and is expected to reach USD 317.18 million by 2030, at a CAGR of 5.8% during the forecast period (2025-2030).

The COVID-19 pandemic significantly impacted the animal sedative market during the initial wave since the veterinary hospital and pharmacy operations were reduced significantly due to several containment measures, such as lockdown and social distancing measures taken by governments across the world. For instance, as per the study published by Faunalytics in December 2022, to avoid disease transmission during the pandemic, around 70% of clinics in the United States and Canada closed their doors to the public, resulting in animals attending visits without their guardians. Also, as per the same source, clinics often ran out of essential supplies. 82% of clinics had pet food, medications, or personal protective equipment shortages. 56% ran out of at least one of those items entirely. Vaccines were in particularly short supply. However, as the pandemic restrictions were eased, the animal sedative market will likely witness growth in the coming years due to the rise in animal surgery cases and the increase in veterinary sedative product launches.

Moreover, the major factors responsible for the growth of the animal sedatives market include a rise in incidences of zoonotic diseases associated with surgical procedures, an increase in the pet population, and growing investment in veterinary product development activities. For instance, 70% of U.S. households, or about 90.5 million families, own a pet, according to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA). Hence, the rise in the pet population indicates an increased concern for pet health. Hence, pet owners will likely invest in pet health care, driving market growth over the forecast period.

Research studies and developments to compare the efficacy of different veterinary sedative products are expected to drive market growth. For instance, as per the article published in December 2022 in Frontiers, a single dosage of romifidine or a combination of romifidine and lidocaine administered epidurally elicited mild to moderate drowsiness and full anti-nociception in the perineal and inguinal regions of donkeys. The technique is convenient for providing analgesia because it is simple, cost-effective, and does not require special or advanced instruments. Hence, such development regarding the utilization of veterinary sedatives is expected to drive market growth over the forecast period.

Additionally, strategic partnerships and product launches by the key players are expected to drive market growth. For instance, in September 2022, Zoetis acquired Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals. Jurox's operations are based in Australia, with additional regional offices in New Zealand, the U.S., Canada, and the U.K. The acquisition of Jurox brings Zoetis a range of important products primed for greater global expansion; a valuable animal health portfolio, including Alfaxan, an anesthetic product for companion animals; and high-quality local R&D and manufacturing operations in Australia, Zoetis' fourth largest market based on revenue in 2021.

Thus, due to the rise in the animal population, an increase in strategic activities by the key players, and an increase in research studies demonstrating the efficacy of sedatives, the studied market is expected to witness notable growth over the forecast period. However, emerging adverse effects of animal sedative drugs, such as respiratory diseases, lowering blood pressure, cardiovascular collapse, etc., and stringent government regulations for sedatives are expected to restrain the market growth over the forecast period.

Animal Sedative Industry Overview

The animal sedative market is moderately competitive and consists of several major players. In terms of market share, a few major players dominate the market. A few key players in the market are Zoetis Inc., Ceva, Merck & Co. Inc., Elanco, Virbac Group, Dechra Pharmaceuticals PLC, Orion Corp., Vetoquinol and Boehringer Ingelheim International GmbH.

Animal Sedative Market Leaders

  1. Elanco

  2. Ceva

  3. Merck & Co. Inc.

  4. Dechra Pharmaceuticals PLC

  5. Zoetis Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Animal Sedative Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Animal Sedative Market News

  • In November 2022, SeQuent Scientific Limited (SeQuent), India's animal health company with a strong presence in veterinary formulations and APIs, signed a definitive agreement to acquire a 100% stake in Tineta Pharma Private Limited (Tineta), a company incorporated in India.
  • In March 2022, the U.S. Food and Drug Administration approved Zenalpha (medetomidine and vatinoxan hydrochlorides injection) as a sedative and analgesic to help keep dogs sedated and comfortable while undergoing exams or certain medical procedures.

Animal Sedative Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Incidence of Zoonotic Diseases
    • 4.2.2 Increasing Incidence of Animal Cancer
    • 4.2.3 Growing Investment in R&D activities to Ensure Quality and Care for Animals
  • 4.3 Market Restraints
    • 4.3.1 Adverse Effects of Animal Sedative Drugs
    • 4.3.2 Stringent Government Regulations for the Sedatives
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Drug Class
    • 5.1.1 Phenothiazines
    • 5.1.2 Benzodiazepines
    • 5.1.3 alpha-2 adrenergic Receptor Agonists
    • 5.1.4 Butyrophenones
    • 5.1.5 Other Drug Classes
  • 5.2 By Application
    • 5.2.1 Surgical
    • 5.2.2 Diagnosis
    • 5.2.3 Clinical Research Studies
  • 5.3 By Route of Administration
    • 5.3.1 Oral
    • 5.3.2 Parenteral
  • 5.4 By Animal Type
    • 5.4.1 Small
    • 5.4.2 Large
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia Pacific
    • 5.5.4 Rest of the World

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Zoetis Inc.
    • 6.1.2 Boehringer Ingelheim International GmbH
    • 6.1.3 Merck & Co. Inc.
    • 6.1.4 Elanco
    • 6.1.5 Virbac Group
    • 6.1.6 Dechra Pharmaceuticals PLC
    • 6.1.7 Orion Corporation
    • 6.1.8 Vetoquinol
    • 6.1.9 Ceva
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Animal Sedative Industry Segmentation

As per the report's scope, animal sedatives are drugs used on animals to reduce irritability and excitement. They are CNS depressants that interact with brain activities and decelerate them. They are injected before any medical procedure on animals. The Animal Sedative Market is Segmented by Drug Class (Phenothiazines, Benzodiazepines, alpha-2 adrenergic Receptor Agonists, Butyrophenones, and Other Drug Classes), Application (Surgical, Diagnosis, and Clinical Research Studies), Route of Administration (Oral and Parenteral), Animal Type (Small and Large), and Geography (North America, Europe, Asia Pacific, and Rest of the World). The report offers the value (in USD million) for the above segments.

By Drug Class Phenothiazines
Benzodiazepines
alpha-2 adrenergic Receptor Agonists
Butyrophenones
Other Drug Classes
By Application Surgical
Diagnosis
Clinical Research Studies
By Route of Administration Oral
Parenteral
By Animal Type Small
Large
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Rest of the World
Need A Different Region or Segment?
Customize Now

Animal Sedative Market Research FAQs

How big is the Global Animal Sedative Market?

The Global Animal Sedative Market size is expected to reach USD 239.27 million in 2025 and grow at a CAGR of 5.80% to reach USD 317.18 million by 2030.

What is the current Global Animal Sedative Market size?

In 2025, the Global Animal Sedative Market size is expected to reach USD 239.27 million.

Who are the key players in Global Animal Sedative Market?

Elanco, Ceva, Merck & Co. Inc., Dechra Pharmaceuticals PLC and Zoetis Inc. are the major companies operating in the Global Animal Sedative Market.

Which is the fastest growing region in Global Animal Sedative Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Animal Sedative Market?

In 2025, the North America accounts for the largest market share in Global Animal Sedative Market.

What years does this Global Animal Sedative Market cover, and what was the market size in 2024?

In 2024, the Global Animal Sedative Market size was estimated at USD 225.39 million. The report covers the Global Animal Sedative Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Animal Sedative Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Animal Sedative Industry Report

Statistics for the 2025 Global Animal Sedative market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Animal Sedative analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Global Animal Sedative Report Snapshots